All links accessed September 2 2019.

1. NICE CKS Menopause. Last revised March 2017. https://cks.nice.org.uk/menopause

2. B Periman et al. ‘The etiology of menopause - not just ovarian dysfunction but also a role for the central nervous system’. Global Reproductive Health. June 2018. 3;2:e8. https://journals.lww.com/grh/Fulltext/2018/06000/The_etiology_of_menopause___not_just_ovarian.1.aspx

3. NHS. Health A to Z. Menopause. Last reviewed August 28-29 2018. https://www.nhs.uk/conditions/menopause/

4. Daisy Network. ‘What is POI’. https://www.daisynetwork.org/about-poi/what-is-poi/

5. KL Szegda et al. ‘Adult adiposity and risk of early menopause’. Human Reproduction. December 2017. 32;12:2522–2531. https://academic.oup.com/humrep/article/32/12/2522/4562350

6. The Migraine Trust. Menopause and migraine. https://www.migrainetrust.org/about-migraine/trigger-factors/menopause-and-midlife/

7. V Beral et al. Collaborative Group on Hormonal Factors in Breast Cancer. ‘Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence’. The Lancet. Published online August 29 2019. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(19)31709-X/fulltext

8. NICE. 2019 surveillance of menopause (NICE guideline NG23). Consultation ended on August 30 2019. https://www.nice.org.uk/consultations/672/11/surveillance-proposal

9. Medicines and Healthcare products Regulatory Agency (MHRA). Press release. ‘HRT users to discuss risks and benefits at next appointment as new study highlights persistent risk of breast cancer’. August 30 2019. https://www.gov.uk/government/news/hrt-users-to-discuss-its-risks-and-benefits-at-their-next-routine-appointment-as-new-study-highlights-persistent-risk-of-breast-cancer

10. MHRA. Drug Safety Update. ‘Hormone replacement therapy (HRT): further information on the known increased risk of breast cancer with HRT and its persistence after stopping’. August 30 2019. https://www.gov.uk/drug-safety-update/hormone-replacement-therapy-hrt-further-information-on-the-known-increased-risk-of-breast-cancer-with-hrt-and-its-persistence-after-stopping

11.NICE. Press and media. ‘Our stance on: Hormone replacement therapy (HRT)’. https://www.nice.org.uk/news/press-and-media

12. Statement emailed in response to enquiry by the author for Independent Community Pharmacist magazine August 30 2019.